van der Louw, E;
van den Hurk, D;
Neal, E;
Leiendecker, B;
Fitzsimmon, G;
Dority, L;
Thompson, L;
... Cross, JH; + view all
(2016)
Ketogenic diet guidelines for infants with refractory epilepsy.
European Journal of Paediatric Neurology
, 20
(6)
pp. 798-809.
10.1016/j.ejpn.2016.07.009.
Preview |
Text
Cross_Ketogenic guidelines for infants.pdf - Accepted Version Download (486kB) | Preview |
Abstract
BACKGROUND: The ketogenic diet (KD) is an established, effective non-pharmacologic treatment for drug resistant childhood epilepsy. For a long time, the KD was not recommended for use in infancy (under the age of 2 years) because this is such a crucial period in development and the perceived high risk of nutritional inadequacies. Indeed, infants are a vulnerable population with specific nutritional requirements. But current research shows that the KD is highly effective and well tolerated in infants with epilepsy. Seizure freedom is often achieved and maintained in this specific patient group. There is a need for standardised protocols and management recommendations for clinical use. METHOD: In April 2015, a project group of 5 experts was established in order to create a consensus statement regarding the clinical management of the KD in infants. The manuscript was reviewed and amended by a larger group of 10 international experts in the KD field. Consensus was reached with regard to guidance on how the diet should be administered and in whom. Results The resulting recommendations include patient selection, pre-KD counseling and evaluation, specific nutritional requirements, preferred initiation, monitoring of adverse effects at initiation and follow-up, evaluation and KD discontinuation. CONCLUSION: This paper highlights recommendations based on best evidence, combined with expert opinions and gives directions for future research.
| Type: | Article |
|---|---|
| Title: | Ketogenic diet guidelines for infants with refractory epilepsy |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ejpn.2016.07.009 |
| Publisher version: | http://dx.doi.org/10.1016/j.ejpn.2016.07.009 |
| Language: | English |
| Additional information: | © 2016. This manuscript version is published under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International licence (CC BY-NC-ND 4.0). This licence allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Further details about CC BY licences are available at http://creativecommons.org/licenses/by/4.0. Access may be initially restricted by the publisher. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Pediatrics, Neurosciences & Neurology, Infant, Ketogenic Diet, Refractory Epilepsy, Guidelines, Intractable Epilepsy, Risk-Factors, Children, Spasms, Growth, Efficacy, Impact, Complications, Urolithiasis, Deficiency |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1508896 |
Archive Staff Only
 |
View Item |
